Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Jorey Chernett, who holds a 10% stake in Oncology Institute, Inc. (NASDAQ: TOI), purchased 25,000 common shares on March 20, 2026, at a weighted average price of $3.35 per share, for a total of $83,750, according to a Form 4 filed with the SEC. The purchase leaves Chernett with 10,276,929 directly owned shares. The buy comes after TOIs stock rose …
Jorey Chernett, a 10% shareholder of AirSculpt Technologies, acquired 40,000 shares of common stock on March 20, 2026, for $110,800. The purchases, executed at prices between $2.73 and $2.79 per share, bring Chernett's direct holdings to 6,793,761 shares. The transaction occurs while the stock trades at $2.86 and amid a pending 15-day filing extens…
Victor Huang, CEO and chairman of Airship AI Holdings, Inc. (NASDAQ: AISP), purchased 40,000 shares of company common stock on March 20, 2026, paying $2.2422 per share for a total of $89,688. Following the trade, Huang directly holds 4,012,567 shares and substantial derivative positions including options, stock appreciation rights, warrants, earnou…
Douglas V. Reynolds, president of Energy Services of America CORP (NASDAQ: ESOA), acquired 6,309 shares of company stock in two transactions valued at roughly $83,327. The insider purchases follow a year-to-date share-price rally and come as the company completed an overallotment sale and highlighted investor materials while declaring a quarterly c…
Felipe Duran, chief financial officer of iBio, Inc., purchased 24,835 shares of the company on March 19, 2026, in multiple transactions at an average price of $2.0186 per share. The purchase, disclosed on a Form 4 filed with the SEC, brought his direct holdings to 35,974 shares. The insider buy comes as iBio reports positive preclinical results for…
Martin Brenner, iBio's CEO and Chief Scientific Officer, purchased 12,336 shares of iBio common stock on March 19, 2026 at $2.02 per share for a total of $24,918, bringing his direct holdings to 30,652 shares. The transaction coincides with recent preclinical obesity data, a $26 million private placement, and analyst Buy ratings and coverage that r…
Keysight Technologies President and CEO Satish Dhanasekaran reported a sale of 1,667 shares on March 19, 2026, bringing proceeds of $483,430. The transaction follows a 79.6% year-over-year gain in the stock, which has since retreated to $277.53. Separately, Keysight announced a slate of product and platform enhancements across Ethernet interconnect…
Executive Vice President Cui Haitao sold 759 shares of Foxx Development Holdings Inc. common stock on March 18 and 19, 2026, for roughly $3,451 across two transactions. The sales left Cui with 136,598 shares after the second trade. The company, with a market capitalization of $28.72 million, carries a 'Weak' financial health assessment from Investi…
Natera co-founder Jonathan Sheena sold a total of 5,360 shares in two pre-arranged transactions on March 18 and March 20, 2026, generating $908,301. The disposition occurred while Natera shares traded near $195.29 and amid analyst debate over valuation and recent clinical and product news from the company.
Director Wu Lei, together with entities Shan Lao Hu Tong LLC and Ji Xiang Hu Tong Holdings LTD, sold 58,990 Class A Ordinary Shares of GigaCloud Technology Inc (NASDAQ: GCT) for about $2.45 million between March 19 and March 20, 2026. The transactions were made under a 10b5-1 trading plan adopted September 24, 2025, which has now concluded. Separat…
Kenneth S. Courtis, a director at Alpha Metallurgical Resources, Inc. (NASDAQ: AMR), executed a series of open-market purchases on March 12, 2026, acquiring company shares totaling $1.53 million at prices between $187.47 and $193.94. The transactions increased Courtis's direct stake in the coal miner to 874,537 shares. The trades occur against the …
Indie Semiconductor's President Ichiro Aoki sold 150,000 shares of Class A common stock between March 18 and March 20, 2026, realizing approximately $388,125. The transactions were carried out under a Rule 10b5-1 plan and coincided with share-price weakness and a number of corporate developments, including a $150 million convertible senior note off…
NVIDIA Executive Vice President and Chief Financial Officer Colette Kress completed a $10.9 million sale of company stock on March 20, 2026, disposing of 68,798 shares at prices between $171.9681 and $177.5122. Two days earlier she sold 76,535 shares at $181.93 to satisfy tax obligations. Following these transactions she directly holds 881,387 shar…
Aarti S. Shah, a member of Nvidia's board, sold 19,000 shares of company stock on March 19, 2026, in three transactions that totaled $3.36 million. The trades were carried out under a Rule 10b5-1 plan adopted in November 2024. The filing, signed March 20, 2026, shows Shah retains 36,007 shares after the sales. The move comes amid mixed price perfor…
Nvidia Executive Vice President Ajay K. Puri sold 299,970 shares of the company's common stock on March 18, 2026, in multiple transactions totaling roughly $54.7 million. On the same date he also sold 69,529 shares to meet tax obligations tied to vesting restricted stock units, a transaction valued at $12.6 million. The shares traded in a range fro…
A Delek US Holdings director, Yemin Ezra Uzi, executed four stock sales on March 18, 2026 under a pre-arranged 10b5-1 trading plan, selling a combined 55,156 shares for roughly $2.43 million. The transactions come while the company's stock is trading close to its 52-week high following a strong 12-month rally, and after the release of fourth-quarte…
A Delek US Holdings director sold 5,000 shares on March 18, 2026, for $45.50 per share, totaling $227,500. The transaction occurred as the stock neared its 52-week high of $46.80 after a 172% gain over the past year. The seller now holds 41,369 shares. The sale was carried out under a pre-arranged 10b5-1 trading plan. Separately, the company report…
Nvidia principal accounting officer Donald F. Robertson Jr. reported multiple stock dispositions in mid-March 2026, including 4,596 shares sold on March 20 for about $942,944 and a separate 4,575-share sale on March 18 to cover taxes valued at $832,329. After these moves Robertson retains direct ownership of 337,120 Nvidia shares. The sales occur a…
Regina A. Tobin, President of Texas Roadhouse Inc, filed a Form 4 disclosing the sale of 4,450 shares on March 19, 2026, for $171.00 apiece, totaling $760,950. The transaction leaves Tobin with 13,778 directly held shares and outstanding restricted stock units vesting in 2027 and 2028. The sale comes after a fourth-quarter 2025 earnings shortfall d…
AppLovin Corp director Eduardo Vivas sold 20,910 shares of Class A common stock on March 13, 2026, at $458.67 per share for approximately $9.5 million. The transaction left Vivas with direct ownership of 7,112,382.249 shares, some of which are represented by restricted stock units, and included a transfer of shares into an exchange-traded fund wher…
Snowflake Inc. director Frank Slootman executed planned stock sales totaling 99,999 shares on March 18 and 19, 2026, generating about $17.5 million. The trades, carried out under a 10b5-1 plan adopted September 19, 2025, coincided with option exercises and follow a year-to-date stock decline of 23.4%, even as the company reported notable revenue gr…
Rui Avelar, an officer at Evolus, Inc. (NASDAQ: EOLS), sold 3,119 shares of common stock on March 20, 2026, in transactions conducted under a pre-established Rule 10b5-1 trading plan to satisfy tax-withholding obligations tied to restricted stock unit settlements. The trades totaled $14,815 at a weighted average price of $4.75 as the stock sits nea…
Evolus President and Chief Executive Officer David Moatazedi sold 13,669 shares on March 20, 2026 under a Rule 10b5-1 plan to satisfy tax withholding tied to restricted stock units, receiving approximately $64,929. The company recently reported fourth-quarter 2025 revenue of $90.3 million, narrowly missing expectations, and moved to rebalance board…
Ekso Bionics Holdings COO Jason C. Jones acquired 1,308 shares on March 16, 2026, through a 401(k) account for $15,499. The transaction comes as the company pursues a private placement and a proposed merger with Applied Digital Cloud to form ChronoScale Corporation; the deal has prompted an analyst downgrade and raises questions about dilution and …
Michael C. Bucella, a director at Terawulf Inc. (NASDAQ: WULF), purchased 1,665 shares on March 20, 2026, spending $25,041 and bringing his direct stake to 280,052 shares. The move comes amid the company closing a $500 million bridge loan for its Hawesville, Kentucky data center and a series of analyst price-target adjustments tied to Terawulf's fo…
